• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS POWERLOC MAX POWER-INJECTABLE INFUSION SET 19G X 1 IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS POWERLOC MAX POWER-INJECTABLE INFUSION SET 19G X 1 IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 84446002
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.The following were reviewed as part of this investigation: patient severity, frequency analysis, applicable previous investigation(s), sample (if available), applicable fmea documents, labeling, and applicable manufacture records.Based on a review of this information, the following was concluded: the complaint a damaged connector is inconclusive due to non-original sample return.One 19 ga x 1 in powerloc max infusion set was returned for investigation.The sample was returned in opened packaging with the protective needle sleeve and white end cap attached.No evidence of use was observed.The sample was flushed with water using a 12 ml syringe and was found to be patent to infusion.The sample was then pressurized and no leaks were observed.The luer hub was found to be within iso tolerance using a calibrated taper gauge.Since no deficiencies matching the complaint description were observed and no evidence of use was present, the complaint of a damaged connector is inconclusive due to non-original sample return.A lot history review (lhr) of asbys0035 showed no other similar product complaint(s) from this lot number.
 
Event Description
It was reported that the hub at the end of the port needle widened so that blood collection was not possible since there was not airtightness created, this happened the second day after placement.A new needle had to be placed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTABLE INFUSION SET 19G X 1 IN
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
Manufacturer (Section G)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
Manufacturer Contact
kelsey erickson
605 n. 5600 w.
salt lake city, UT 84116
8015225937
MDR Report Key7899758
MDR Text Key121565183
Report Number3006260740-2018-02550
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00801741048111
UDI-Public(01)00801741048111
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K153440
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Reporter Occupation Nurse
Type of Report Initial
Report Date 09/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number84446002
Device Lot NumberASBYS0035
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/12/2018
Is the Reporter a Health Professional? Yes
Event Location Outpatient Treatment Facility
Date Manufacturer Received09/12/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-